Literature DB >> 7957432

Low dose inhaled nitric oxide causing selective pulmonary vasodilation in child with idiopathic pulmonary hypertension.

P Radermacher1, S Rammos.   

Abstract

Low dose (3 ppm) inhaled nitric oxide caused selective pulmonary vasodilation with improved systemic arterial pressure, cardiac index and arterial oxygenation in an infant with primary pulmonary hypertension. Methaemoglobin levels did not exceed 0.6%, and nitrogen dioxide concentrations remained within 0.05 ppm.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7957432     DOI： 10.1007/BF02190694

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  11 in total

1.  Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn.

Authors:  J P Kinsella; S R Neish; E Shaffer; S H Abman
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

2.  The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin.

Authors:  Q H GIBSON; F J ROUGHTON
Journal:  J Physiol       Date:  1957-05-23       Impact factor: 5.182

3.  Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.

Authors:  L J Rubin; J Mendoza; M Hood; M McGoon; R Barst; W B Williams; J H Diehl; J Crow; W Long
Journal:  Ann Intern Med       Date:  1990-04-01       Impact factor: 25.391

4.  Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.

Authors:  J Pepke-Zaba; T W Higenbottam; A T Dinh-Xuan; D Stone; J Wallwork
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

5.  Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome.

Authors:  H Gerlach; R Rossaint; D Pappert; K J Falke
Journal:  Eur J Clin Invest       Date:  1993-08       Impact factor: 4.686

6.  Inhalation of nitric oxide reduced pulmonary hypertension after cardiac surgery in a 3.2-kg infant.

Authors:  H Selldén; P Winberg; L E Gustafsson; B Lundell; K Böök; C G Frostell
Journal:  Anesthesiology       Date:  1993-03       Impact factor: 7.892

7.  Inhaled nitric oxide in congenital heart disease.

Authors:  J D Roberts; P Lang; L M Bigatello; G J Vlahakes; W M Zapol
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

8.  Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension.

Authors:  J P Kinsella; W H Toews; D Henry; S H Abman
Journal:  J Pediatr       Date:  1993-05       Impact factor: 4.406

9.  Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

Authors:  J D Roberts; D M Polaner; P Lang; W M Zapol
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

10.  Inhaled nitric oxide for the adult respiratory distress syndrome.

Authors:  R Rossaint; K J Falke; F López; K Slama; U Pison; W M Zapol
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245
View more
  1 in total

1.  Prostacyclin aerosol in an infant with pulmonary hypertension.

Authors:  B Santak; M Schreiber; P Kuen; D Lang; P Radermacher
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.